Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.37 USD | +1.56% | -3.00% | +32.37% |
05-24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
05-21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.37% | 2.75B | |
+17.17% | 124B | |
+19.29% | 112B | |
+3.52% | 22.94B | |
-11.92% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+3.51% | 13.63B | |
+22.79% | 11.61B | |
+108.68% | 10.31B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Transcript : PTC Therapeutics, Inc. - Special Call